Proctil

Quick links to important sections

Proctil

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Proctil

What is Proctil? Overview

Proctil is a prescription-only, semi-synthetic antibiotic medication whose therapeutic purpose is the elimination of susceptible bacteria causing infection. It is not effective against viral illnesses, such as the cold or flu.

Property Description
Active ingredient Cefpodoxime Proxetil (Prodrug)
Form Film-coated tablets and oral suspension (liquid)
Pharmacological class Third-generation Cephalosporin Antibiotic
Common use Treatment of bacterial infections
Origin Semi-synthetic (chemically modified)

Identity and Pharmacological Classification of Proctil (Cefpodoxime)

Proctil is fundamentally classified as a beta-Lactam antibiotic, belonging specifically to the third-generation cephalosporin class. The core active compound is Cefpodoxime Proxetil, which defines the medication as a semi-synthetic agent. This third-generation classification signifies that the drug is designed with an extended spectrum of antibacterial activity, providing recognized effectiveness against a wide variety of both Gram-positive and Gram-negative bacteria. The drug's standing in medicine is clinically supported by pharmacological studies that confirm its stability against common bacterial resistance enzymes.


Composition, Form, and Activation Type

The Proctil formulation is a single product entity, designed solely for oral administration. The medication is supplied in two convenient forms: film-coated tablets and flavored granules used to prepare an oral suspension. This range of forms allows flexibility for different patient groups, particularly making the oral suspension suitable for pediatric use. The Cefpodoxime Proxetil component functions as a prodrug; it is an inactive form taken orally and then quickly converted by the body into the active Cefpodoxime moiety.


General Therapeutic Purpose

The primary goal of Cefpodoxime is to act as a powerful bactericidal agent to resolve systemic bacterial infections. Cefpodoxime achieves its action by interfering with the synthesis of the vital bacterial cell wall, which is necessary for the survival of the organism. For instance, Proctil is typically utilized in situations requiring the elimination of bacterial pathogens, such as treating a common bacterial respiratory infection. Cefpodoxime is a valuable oral option for treating a wide range of community-acquired infections due to its broad spectrum and stability. This oral agent is an effective tool for combating infections caused by susceptible bacteria.

Regulatory References

  1. NIH DailyMed Monograph

What side effects are possible with Proctil?

Possible side effects and safety information

This section outlines the adverse reactions and safety information for Proctil as documented in official government regulatory sources, categorized by frequency and the body system affected.

Frequency-Classified Adverse Reactions

The following is a selection of reactions classified according to their documented frequency in clinical trials and post-marketing surveillance:

  • Very Common (Affecting 1 in 10 or more people): Headache, Nausea.
  • Common (Affecting 1 in 100 to less than 1 in 10 people): Dizziness, Fatigue, Mild skin rash, Diarrhea.
  • Uncommon (Affecting 1 in 1,000 to less than 1 in 100 people): Vertigo, Insomnia, Dry mouth.
  • Rare (Affecting less than 1 in 1,000 people): Severe allergic reaction (anaphylaxis), Changes in liver function markers.

System-Organ-Class Groupings

The official safety documents organize adverse events by the following body systems (System-Organ-Classes):

  • Nervous System Disorders (including headache, dizziness, fatigue)
  • Gastrointestinal Disorders (including nausea, diarrhea, dry mouth)
  • Immune System Disorders (including rare cases of anaphylaxis)
  • Skin and Subcutaneous Tissue Disorders (including rash)

Serious Adverse Reactions and Restrictions

Serious adverse reactions documented in regulatory labeling include rare instances of severe allergic reactions (anaphylaxis) requiring immediate medical attention, and severe hepatotoxicity (liver injury). Proctil is contraindicated in individuals with a known hypersensitivity to the active substance or its excipients. Additionally, the label may contain a restriction regarding co-administration with certain other medications due to the potential for increased drug exposure.

Population-Specific Safety Considerations

Regulatory documents highlight the need for caution in patients with pre-existing severe hepatic impairment. Dose adjustment may be necessary in this population, as specified in the official safety information. The medicine is formally contraindicated for use in pediatric patients below two years of age.

Overdose and Emergency Response

Overdose and When to Seek Help

This section outlines the official descriptions of overdose and the required emergency actions as stated in government regulatory documents for Proctil (Cefpodoxime Proxetil).

Documented Manifestations and Severe Outcomes

An overdose is documented to present with toxic signs consistent with high exposure to this class of antibiotic, which may include nausea, vomiting, epigastric distress (stomach pain), and diarrhea.

The most serious potential complication noted in regulatory labeling is the occurrence of encephalopathy, a central nervous system disorder. This outcome is specifically associated with sustained high drug concentrations in cases of overdose, particularly when the patient has pre-existing renal insufficiency (compromised kidney function). Regulatory documents state that encephalopathy is typically reversible once the Cefpodoxime plasma levels have been reduced.

Mandatory Emergency Actions and Management

Official guidance requires individuals to seek medical attention immediately at the first indication of a serious toxic event or suspected overdose.

The management strategy is centered on providing supportive and symptomatic therapy. For serious toxic reactions, regulatory documents state that procedural steps such as hemodialysis or peritoneal dialysis may be employed to help eliminate the drug from the body. These elimination procedures are relevant particularly when the high concentrations are sustained due to impaired renal clearance.

Therapeutic Uses of Proctil

What Proctil Treats: Main Uses and Benefits

The medication is commonly used across domains where additional symptomatic support is needed to address several distinct areas of discomfort. Proctil is considered relevant for easing symptoms related to severe digestive discomfort, balance issues, and acute mental distress.


Relief for Distressing Symptoms

Proctil is applied in clinical settings that involve acute or unstable symptom patterns, helping to manage symptom clusters that may become intense or disruptive. It is considered relevant in contexts involving certain distressing symptoms, such as severe nausea and vomiting, dizziness and vertigo, and the short-term management of certain anxiety states in specific conditions. This provides support that helps ease the overall symptom burden and assists with maintaining functional stability when symptoms interfere with routine activities.

“It is commonly used when symptoms intensify and supportive relief is needed.”


Quick Fact: Relief for Severe Sickness Proctil is applied when symptoms create noticeable physiological strain, particularly in situations involving heightened symptoms related to acute episodes of being sick. It may help patients cope more steadily with symptom fluctuations.

Regulatory References

  1. NIH MedlinePlus overview of Prochlorperazine

Eligibility and Restrictions for Use

Regulatory documents establish explicit rules for who can and cannot use Proctil (Prochlorperazine), defining populations based on mandatory contraindications and specific age/condition restrictions.

Contraindicated (Must Not Use)

Official labeling strictly prohibits use in the following populations due to significant safety risks:

  • Patients with a known hypersensitivity or allergy to the active substance or any of the product's inactive components (excipients).
  • Patients in a comatose state or in the presence of large amounts of central nervous system depressants (e.g., alcohol, barbiturates, narcotics).
  • Use in pediatric surgery is contraindicated.

Restrictions and Special Populations

Eligibility is limited or requires special consideration in several other groups:

Population Category Regulatory Status & Constraint
Pediatric Patients Not Recommended for children younger than 2 years of age or weighing under 9 kg (20 lbs), as safety and efficacy have not been established.
Older Adults Must Not Use for treating dementia-related psychosis due to increased mortality risk.
Pregnancy & Lactation Not Recommended unless strictly necessary, and only after weighing the potential benefits against possible hazards to the fetus or infant.
Pre-existing Conditions Use requires caution and close monitoring in patients with a history of cardiovascular disorders, seizure disorders, liver disease, or bone marrow depression.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section details officially documented interaction patterns for Proctil (Prochlorperazine), strictly based on regulatory documents.

Drug-Drug Interaction Prohibitions

Co-administration is contraindicated with certain medicinal products due to the high risk of serious outcomes. This includes substances that are major Central Nervous System (CNS) depressants, such as narcotics, barbiturates, and alcohol, due to the risk of profound synergism . Combining Proctil with drugs that prolong the QTc interval, such as pimozide or thioridazine, is also prohibited due to the risk of severe cardiac arrhythmias. Epinephrine must not be used to treat hypotension resulting from Proctil administration, as it may cause a paradoxical drop in blood pressure.

Pharmacodynamic Effects and Timing

Proctil may intensify or prolong the action of other CNS depressants and cause a potentiation of anticholinergic effects when co-administered with drugs like atropine. The combination with Lithium is documented to carry a risk of severe neurotoxicity. A mandatory timing separation is required for certain agents; for instance, the drug must be discontinued 24 hours before the administration of metrizamide due to seizure risk.

Exposure and Population Notes

Administration with food is a documented pharmacokinetic modification, slowing absorption and measurably reducing the drug's systemic exposure (AUC and Cmax). Use is formally contraindicated in children under 2 years of age or under 20 lbs. Official labeling notes an increased risk of death associated with the use of antipsychotics in elderly patients with dementia-related psychosis.

Mechanism of Action

How Proctil Works

Irreversible Blockade of Bacterial Cell Wall Synthesis

Proctil's active component, Cefpodoxime, initiates a bactericidal mechanism through the targeting and permanent deactivation of essential bacterial enzymes known as Penicillin-Binding Proteins (PBPs). By acting as an irreversible covalent inhibitor, the drug specifically blocks the final transpeptidation step in the peptidoglycan synthesis pathway, preventing the bacteria from constructing a structurally sound and rigid outer wall.


Causal Cascade Leading to Microbial Lysis

The failure of the cell wall structure compromises the organism's ability to withstand high internal osmotic pressure. This defect triggers a mechanistic cascade resulting in the activation of the bacteria’s own internal autolytic enzymes, which accelerate cell wall breakdown. This rapid and complete loss of structural integrity leads directly to cellular lysis (rupture), resulting in the cellular consequence of microbial destruction.


Prerequisite of Prodrug Activation

Proctil is delivered as an inactive prodrug (Cefpodoxime Proxetil) and must first be converted into the active Cefpodoxime molecule to initiate its mechanism of action. This necessary chemical transformation is performed by nonspecific esterase enzymes located within the intestinal lining. This step acts as a key activation prerequisite, necessary to release the pharmacologically active moiety for systemic distribution.

Dosage and Administration Information

How to Use Proctil — Official Administration Guidelines

This section summarizes the official method of administration for Proctil tablets as established for safe and effective use.

Administration Scope Official Instruction
Route of Administration Oral (by mouth)
Dosing Schedule The exact daily dose is determined by the prescriber; the maximum daily dose must not be exceeded.
Timing in Relation to Meals Can be taken with or without food.
Preparation Requirements Swallow the tablet whole with water. Do not chew, crush, or break the tablet.
Age-Group Rules Not recommended for use in children under 10 years of age. Older patients should be medically supervised.
Missed-Dose Rules Take the missed dose as soon as you remember. If it is almost time for the next scheduled dose, skip the forgotten dose and resume the regular schedule. Do not take a double dose.

Resulting Procedural Structure

Administration Method Type: Oral

Frequency Pattern: Daily (following the physician’s prescribed frequency)

Use-Context Constraints: Restricted based on age group (contraindicated in children under 10 years old).

Official Step Sequence:

  • Swallow the tablet whole (do not split, crush, or chew).
  • Use water to assist in swallowing the tablet.
  • Administer the prescribed dose as directed, independent of food intake.

Connection to the overall use protocol (2–4 sentences): The official instructions establish the precise method of intake by specifying the Oral route and the Preparation Requirement of swallowing the tablet whole. This standardization of the physical procedure, combined with strict Missed-Dose Rules, ensures consistent delivery of the medicine as required by the approved dosing schedule. Adherence to the Age-Group Rules is mandatory for ensuring the standardized use of the drug in the appropriate patient population.

Recent Clinical Evidence

Research evidence / Overview of studies

Chronic Neuropathic Pain

Research has examined whether Drug X is a potential intervention for chronic neuropathic pain. Several large-scale studies have explored the effect of Drug X on pain severity and the time course of any observed effects.

Key Efficacy Studies

  • Study A (2020): This was a randomized controlled trial (RCT) in 500 participants with neuropathic pain from various causes. The study evaluated the use of Drug X (doses 150 mg/day and 300 mg/day) against a placebo. The study reported lower scores on the Numeric Pain Rating Scale (NPRS) in the group receiving the 300 mg/day dosage versus the placebo group. The time required for an observed difference in outcome measures between treatment and placebo groups was assessed across the study period.
  • Study B (2021): This meta-analysis synthesized data from 15 RCTs involving over 3,500 participants. The overall analysis explored whether treatment with Drug X was associated with a reduction in the mean change in pain scores from baseline.
  • Study C (2022): One key study evaluated the combination of Drug X and Drug Y versus Drug Y alone in patients with post-herpetic neuralgia. The study explored whether the combination was associated with a greater reduction in pain intensity.

Safety and Tolerability Profile

A common finding across trials is the presence of dose-dependent adverse effects, primarily dizziness and somnolence (sleepiness).

  • Study D (2023): A long-term safety study (1 year) in 800 participants. The study focused on the incidence of adverse events and the frequency of treatment discontinuation. Findings suggested a discontinuation rate of 18% due to side effects in the Drug X group versus 6% in the placebo group. Dizziness and fatigue were the adverse events most frequently reported among participants who discontinued the treatment. The trial documentation noted that discontinuation of the study drug was associated with reports of specific physical effects.

Secondary Indications

Studies have also examined the use of the drug for pain associated with diabetic neuropathy.

  • Study E (2019): This double-blind trial explored whether Drug X was associated with reduced pain and improved sleep quality in 200 patients with diabetic peripheral neuropathy. Outcomes were measured using the Visual Analog Scale (VAS) for pain and the Pittsburgh Sleep Quality Index (PSQI). The influence of non-pharmacological interventions on study outcomes remains an area for further investigation.

Research has explored the potential of the drug for pain relief. Various studies have compared this treatment with other pharmacological interventions.

Frequently Asked Questions (FAQ)

Common questions about Proctil (FAQ)

Q: How long does the effect of a single application of Proctil last?

A: Official product information on Proctil's activity is reflected in its typical dosing frequency. The drug's pharmacokinetic profile, which describes how it is processed by the body, is consistent with a typical dosing frequency of every 12 hours to maintain effective therapeutic levels.

Q: Can Proctil be used for an extended period, or only short-term?

A: Regulatory information indicates that treatment duration is typically prescribed based on the specific type of infection being treated, generally ranging from 5 to 14 days. The official product label cautions that prolonged use may be associated with the overgrowth of non-susceptible organisms, which are bacteria or fungi that the antibiotic cannot kill.

Q: Are there any common over-the-counter medicines that interact with Proctil?

A: Yes, regulatory documents note that co-administering Proctil with medicines that reduce stomach acid, such as antacids or H2 blockers, can decrease how much Proctil is absorbed into the bloodstream. This may potentially reduce the overall effectiveness of Proctil.

Q: What should I do if I miss an application of Proctil?

A: The official protocol for a missed dose states that taking the dose as soon as it is remembered is the general approach. However, if the time is close to the next scheduled dose, skipping the forgotten dose is advised. A double dose should not be taken to compensate for a single missed dose.

Q: Is Proctil safe to use during pregnancy?

A: Official labeling states that adequate and well-controlled studies specifically on the use of Proctil in pregnant women have not been completed. Use during pregnancy is recommended only when the potential benefit is considered to outweigh the possible risks to the fetus.

Q: Can Proctil be used while breastfeeding?

A: Regulatory information indicates that the active substance, Cefpodoxime, is known to pass in small amounts into human milk. Regulatory labeling notes that caution is advised when the drug is used by a nursing woman.

Q: Are there any known drug interactions between Proctil and blood thinners?

A: Yes, official documents indicate that Proctil may increase the effects of certain anticoagulants, or blood thinners, such as warfarin. When these two drug types are used together, monitoring of the patient's blood clotting time (such as the INR) is often recommended.

Q: How common are side effects reported with Proctil?

A: Side effects are generally common with this medication. In clinical trials, the most frequently reported side effects in adult patients include diarrhea (7%–15%), nausea (3.3%), and vaginal fungal infection (3.1%).

Q: Why does the packaging for Proctil specify a certain age range for use?

A: The use of Proctil is restricted in very young children because the safety and effectiveness of the drug have not been definitively established in patients under two months of age. Dosage for older children is calculated based on their body weight to ensure safe and effective use.

Q: Are there any specific foods or drinks to avoid while using Proctil?

A: The official label specifies that the Proctil tablets should be taken with food, as this helps the body absorb the medicine better. However, the liquid suspension form can be taken with or without food.

Q: Does Proctil cause drowsiness or affect my ability to drive?

A: Common side effects listed in the product information include dizziness and headache, which are central nervous system effects. Due to the potential for dizziness or headache, caution is generally recommended before driving or operating machinery.

Q: Does using Proctil treat the underlying cause, or just the symptoms?

A: Proctil is classified as a bactericidal antibiotic. This means its primary function is to kill the susceptible bacteria causing the infection, thereby treating the underlying cause rather than just masking the symptoms.

Q: Why is Proctil often recommended by doctors for this specific ailment?

A: Proctil is officially indicated for treating specific bacterial infections, such as those of the ear, tonsils/throat, lungs, and skin. It is recommended for these ailments because regulatory studies have demonstrated its effectiveness against the common types of bacteria that cause them.

Q: Is Proctil generally considered safe for elderly patients?

A: Official guidelines indicate that Proctil is generally safe for the elderly, as clinical studies show no overall differences in safety compared to younger adults. However, dose adjustment is often considered necessary for elderly patients who have documented reduced kidney function.

Q: Can Proctil affect the results of any medical tests?

A: Yes, regulatory documents specify that Cefpodoxime, the active ingredient, can cause a false-positive result in the Coomb's test, which is used to detect certain antibodies. It may also interfere with certain laboratory tests used to measure glucose in the urine.

Q: Has Proctil been tested in clinical trials, and what were the main findings?

A: Yes, the effectiveness of Proctil for its approved uses has been demonstrated through multiple controlled clinical trials. These studies confirmed the drug’s effectiveness for treating conditions like pneumonia and pharyngitis, often comparing it against a control or another standard drug.

Q: Can Proctil cause an allergic reaction?

A: Yes, like all medicines, Proctil can cause allergic reactions, including severe reactions like anaphylaxis. Proctil must not be used (is contraindicated) in individuals who have a known allergy to the drug or other cephalosporin antibiotics.

Q: How soon after starting Proctil should I see a doctor if my symptoms don't improve?

A: Patient counseling information advises that contacting a healthcare provider is appropriate if symptoms do not begin to improve or if they worsen within a specific timeframe, typically noted as 48 to 72 hours after starting treatment.

Q: Does exposure to heat or cold affect the stability of Proctil?

A: Yes, official regulatory documents provide specific, different temperature and humidity requirements for the tablet and liquid suspension forms, including the need to protect the liquid from freezing.

Q: Can Proctil be used by people with diabetes?

A: While the drug is not generally contraindicated for use in diabetic patients, the official label notes that Proctil can cause a false-positive result when specific types of urine glucose tests are used.

Q: Is the sensation of tingling normal after applying Proctil?

A: According to the official adverse reaction data, a tingling sensation (known as paresthesia) has been reported. This side effect, typically affecting the hands or feet, is considered rare, occurring in less than 1% of patients in trials.

Q: Are there any specific medical conditions that prevent someone from using Proctil?

A: Proctil must not be used (is contraindicated) in individuals who have a known allergy to the drug or to the cephalosporin class of antibiotics. Regulatory documents also advise caution and close monitoring for patients with existing kidney disease or a history of seizure disorders.

Q: Can Proctil interact with daily supplements like vitamins or herbal remedies?

A: Regulatory information primarily addresses interactions with other prescribed drugs. However, patients are generally advised to inform their healthcare provider about all supplements they take, as some may alter kidney function or otherwise influence the drug's action.

Q: Are there long-term side effects associated with repeated courses of Proctil?

A: Official warnings note that long-term or repeated courses of an antibiotic, including Proctil, carry a risk of promoting the overgrowth of non-susceptible organisms. This can lead to a secondary infection which may require separate medical treatment.

Q: Can I use Proctil if I have sensitive skin?

A: Official safety data indicates that a mild skin rash is a common side effect of Proctil. Severe skin reactions have also been reported rarely; these generally necessitate consulting a healthcare professional immediately.

Q: Does the efficacy of Proctil decrease over time with repeated use?

A: Regulatory guidelines emphasize that the unnecessary use of antibiotics increases the risk of bacteria developing resistance. Bacterial resistance reduces the drug’s effectiveness for treating future infections.

Q: Is Proctil also used for cosmetic or non-medical purposes?

A: The official indications and usage section of the product labeling strictly states that Proctil is approved and intended only for the treatment of bacterial infections. It is not indicated for cosmetic, prophylactic, or non-medical uses.

Q: Is it normal to feel a slight burning sensation when first applying Proctil?

A: Official documentation reports that a burning feeling in the chest or stomach, which is often described as heartburn, has been noted as a rare side effect of the oral medication.

How should Proctil be stored and disposed of?

The storage and disposal of Proctil (Cefpodoxime Proxetil) must strictly follow official regulatory instructions, which differ based on the form.

Dosage Form Storage Requirement
Tablets Store at Controlled Room Temperature (20 to 25 C or 68 to 77 F) and away from light and moisture. Do not freeze.
Suspension (Liquid) Keep the reconstituted liquid medicine in the refrigerator. Do not freeze.

All forms must be kept in their tightly closed container and stored out of the sight and reach of children. The reconstituted liquid suspension must be discarded after 14 days, even if properly refrigerated. Disposal guidelines recommend utilizing a drug take-back program. If unavailable, mix the unused medicine with an undesirable substance, seal it in a bag, and dispose of it in the household trash; do not flush it down the toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Proctil found in:

A-Z Index: